Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Rosqvist, Kristinaa; * | Odin, Pera; b; c | Hagell, Peterd | Iwarsson, Susannee | Nilsson, Maria H.e; f | Storch, Alexanderg; h
Correspondence: [*] Correspondence to: Kristina Rosqvist, Restorative Parkinson Unit, Skåne University Hospital, Forskningsenhet Neurologi, Wigerthuset, Remissgatan 4, plan 1, SE-221 85 Lund, Sweden. E-mail: [email protected].
Abstract: Background:Non-motor symptoms (NMS) are common in late stage Parkinson’s disease (PD), as the frequency and severity of most of these symptoms increase with advancing disease. Objective:To assess effect of dopaminergic therapy on NMS in late stage PD and to investigate relationships between dopaminergic effect on NMS and on motor function. Method:Thirty PD patients in Hoehn and Yahr (HY) stages IV and V in “on” were included. Dopaminergic effect on non-motor symptomatology was assessed by the modified version of the Non-Motor Symptoms Scale (NMSS) in the “off” and the “on” state during a standardized L-dopa test, in parallel also assessing motor function. Results:NMS were common and many of the symptoms occurred in >80% of the individuals. The highest NMSS scores were seen within the NMSS domains 3: mood/apathy and 7: urinary in both the “off” and the “on” state. There was a statistically significant (p < 0.001) improvement in the modified NMSS total score (median) from 79 in “off” to 64 in “on”. There were statistically significant differences between the “off” and the “on” state for domains 2: sleep/fatigue, 3: mood/apathy, 5: attention/memory, 6: gastrointestinal and 7: urinary. The differences in the NMSS score between the “off” and the “on” state were in general larger for motor responders than for motor non-responders. In motor non-responders, differences of the NMSS score between the “off” and the “on” state were found for the total score, domain 3: mood/apathy and its item 11-flat moods. Conclusion:There is an effect of dopaminergic medication on NMS in late stage PD, to some extent also for those with a non-significant response on motor function during L-dopa test. It is therefore of importance to optimize dopaminergic therapy in order to give the most effective symptomatic treatment possible.
Keywords: Parkinson’s disease, levodopa, levodopa test, late stage, non-motor symptoms, fluctuations, mood, apathy, fatigue, sleep
DOI: 10.3233/JPD-181380
Journal: Journal of Parkinson's Disease, vol. 8, no. 3, pp. 409-420, 2018
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]